undamentalytics Newsletter
Sign in

Invivyd, Inc. cash flow statement

In fiscal 2025, Invivyd, Inc.'s operations generated −$58.1m of cash; it spent $155,000 on capital projects, leaving free cash flow of −$58.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−173−170−58−108
Depreciation and amortisation0———
Stock-based pay19201211
Capital spending1001
Free cash flow−174−171−58−110
Free cash flow after stock pay−192−190−70−121
Share buybacks00——
Shares issued0000

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: FENC vs IVVDIVVD vs NTLAIVVD vs NKTR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Invivyd, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Invivyd, Inc.